Morgan Stanley’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40.6M Sell
3,573,976
-16,849
-0.5% -$191K ﹤0.01% 2118
2025
Q1
$23.9M Buy
3,590,825
+153,581
+4% +$1.02M ﹤0.01% 2520
2024
Q4
$37.9M Sell
3,437,244
-768,063
-18% -$8.47M ﹤0.01% 2091
2024
Q3
$51.7M Buy
4,205,307
+726,510
+21% +$8.93M ﹤0.01% 1795
2024
Q2
$47M Sell
3,478,797
-546,205
-14% -$7.38M ﹤0.01% 1819
2024
Q1
$54.3M Sell
4,025,002
-2,715,722
-40% -$36.7M ﹤0.01% 1685
2023
Q4
$35.5M Buy
6,740,724
+3,826,940
+131% +$20.1M ﹤0.01% 2814
2023
Q3
$11.5M Sell
2,913,784
-7,292
-0.2% -$28.7K ﹤0.01% 3001
2023
Q2
$31.1M Sell
2,921,076
-3,452
-0.1% -$36.7K ﹤0.01% 2029
2023
Q1
$24.4M Buy
2,924,528
+470,842
+19% +$3.92M ﹤0.01% 2209
2022
Q4
$22.6M Sell
2,453,686
-158,356
-6% -$1.46M ﹤0.01% 2212
2022
Q3
$33.5M Sell
2,612,042
-3,832
-0.1% -$49.2K ﹤0.01% 1662
2022
Q2
$34.6M Buy
2,615,874
+63,745
+2% +$842K ﹤0.01% 1703
2022
Q1
$53.7M Buy
2,552,129
+2,428,519
+1,965% +$51.1M 0.01% 1259
2021
Q4
$2.97M Sell
123,610
-18,115
-13% -$435K ﹤0.01% 4249
2021
Q3
$3.61M Sell
141,725
-52,765
-27% -$1.34M ﹤0.01% 4060
2021
Q2
$6.55M Sell
194,490
-22,445
-10% -$756K ﹤0.01% 3489
2021
Q1
$8.43M Buy
216,935
+205,971
+1,879% +$8M ﹤0.01% 2827
2020
Q4
$679K Buy
10,964
+7,899
+258% +$489K ﹤0.01% 4889
2020
Q3
$102K Sell
3,065
-47,525
-94% -$1.58M ﹤0.01% 5429
2020
Q2
$1.21M Buy
50,590
+45,489
+892% +$1.08M ﹤0.01% 4026
2020
Q1
$117K Sell
5,101
-12,398
-71% -$284K ﹤0.01% 5124
2019
Q4
$496K Buy
17,499
+11,459
+190% +$325K ﹤0.01% 4927
2019
Q3
$130K Buy
6,040
+2,490
+70% +$53.6K ﹤0.01% 5347
2019
Q2
$104K Buy
+3,550
New +$104K ﹤0.01% 5303